The Face of Diabetes: Honoring Courage and Community, June 14th

Celebrating strength and resilience in the Rio Grande Valley

Translate to Spanish or other 102 languages!

The Rio Grande Valley Diabetes Association (RGVDA) will host “The Face of Diabetes,” a special event celebrating the determination and resilience of individuals with diabetes. Scheduled for Saturday, June 14th, from 11:00 AM to 1:00 PM at the Radisson McAllen Hotel Airport, the event aims to recognize local community members who continue to face the challenges of diabetes with strength, dignity, and hop. Courtesy image. Bgd for illustration purposes
The Rio Grande Valley Diabetes Association (RGVDA) will host “The Face of Diabetes,” a special event celebrating the determination and resilience of individuals with diabetes. Scheduled for Saturday, June 14th, from 11:00 AM to 1:00 PM at the Radisson McAllen Hotel Airport, the event aims to recognize local community members who continue to face the challenges of diabetes with strength, dignity, and hop. Courtesy image. Bgd for illustration purposes
- Advertisement -

Mega Doctor News

The Rio Grande Valley Diabetes Association (RGVDA) will host “The Face of Diabetes,” a special event celebrating the determination and resilience of individuals with diabetes. Scheduled for Saturday, June 14th, from 11:00 AM to 1:00 PM at the Radisson McAllen Hotel Airport, the event aims to recognize local community members who continue to face the challenges of diabetes with strength, dignity, and hope.

This annual celebration will spotlight inspiring individuals whose stories exemplify perseverance and advocacy in the face of a chronic illness. Honorees include Amir Elsayed, Dr. Ofelia Averack, Judge Hector Bustos, Suzy Yoon Lee, Diana Stansberry, Rosie Aguirre, Armando Salinas, Visha Daniec, Natalie Buentello, Roy Cantu, Melba Gutierrez, Dr. Rosalva Dehoyos, Mike Robledo, Candace Rodriguez, Edward Polaco, and Rick Aguirre.

- Advertisement -
Courtesy image

In addition to the awards ceremony, the event will feature a fashion show with models from the Debi Lou Modeling Academy. Macy’s will provide the latest apparel for the runway, adding a stylish flair to the meaningful occasion.

The RGVDA, founded in 2007 and based in McAllen, Texas, is a nonprofit organization dedicated to preventing diabetes and reducing its complications through education, early detection, and community outreach. All funds raised are used locally to support diabetes management programs, meal planning education, and support groups for children and adults.

As of 2025, the organization is led by President and Founder Dr. Monzer H. Yazji, MD, with Dr. Luis Reyes serving as Chairman. The board of directors includes Amir Elsayed, Victor Daniec, and Iliana Guerra Martinez, RD, LD, CDE.

For ticket details or more information, the public should contact the RGVDA at (956) 318-1900 or visit their office at 3200 N. 23rd St., Suite A, McAllen, TX 78501. Additional resources are available at rgvda.org.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -